• Korro Bio director Jean Francois Formela reported sales totaling 110,223 common shares on July 2-6.
• Shares sold at weighted-average prices of USD 14.03 on July 2, USD 13.96 on July 6.
• Post-transaction holdings: 706,556 shares indirectly owned, 146,305 shares indirectly owned.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Korro Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001030575-26-000006), on July 07, 2026, and is solely responsible for the information contained therein.